AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2010

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
Tax period
2010-06-01 to 2011-05-31
Filed
2012-04-02
IRS object ID
201230939349300508
Schema version
2010v3.4
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2012-04-02T09:46:37-05:00Timestamp
Tax Period End Date2011-05-31TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1TATE AND TRYONBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line12021 L STREET NW SUITE 400AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20036ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2010-06-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN237033369EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEMBusinessNameLine1
Business Name Line2PHARMACISTS RESEARCH AND EDUCATION FDTNBusinessNameLine2
FieldValueIRS element (for citing)
Name ControlAMERNameControl
Phone3016648612Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameSTEPHEN J ALLENName
TitleEXECUTIVE VICE PRESIDENT AND CEOTitle
Phone3016648612Phone
Date Signed2012-04-02DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameDEBORAH G KOSNETTName
Phone2022932200Phone
FieldValueIRS element (for citing)
Tax Year2010TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonSTEPHEN J ALLENNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode
FieldValueIRS element (for citing)
Gross Receipts4297100GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.ASHPFOUNDATION.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1968YearFormation
State Legal DomicileMDStateLegalDomicile
Activity Or Mission DescriptionFOSTERING SAFE AND EFFECITVE MEDICATION USE. TO PROMOTE THE PUBLIC INTEREST THROUGH DEVELOPMENT OF HIGH QUALITY PHARMACEUTICAL SERVICES IN HEALTH SYSTEMS. TO ENCOURAGE, PROVIDE FOR AND ENGAGE IN SCIENTIFIC RESEARCH, PROFESSIONAL STUDY AND ADVANCEMENT OF THE SCIENCE OF PHARMACY IN HEALTH SYSTEMS. TO IMPROVE THE QUALITY AND INCREASE THE AVAILABILITY OF PHARMACEUTICAL SERVICES TO THE PUBLIC.ActivityOrMissionDescription
Nbr Voting Members Governing Body10NbrVotingMembersGoverningBody
Nbr Independent Voting Members8NbrIndependentVotingMembers
Total Nbr Employees0TotalNbrEmployees
Total Nbr Volunteers100TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year1993575ContributionsGrantsPriorYear
Contributions Grants Current Year2697502ContributionsGrantsCurrentYear
Program Service Revenue Prior Year155612ProgramServiceRevenuePriorYear
Program Service Revenue CY216540ProgramServiceRevenueCY
Investment Income Prior Year1220437InvestmentIncomePriorYear
Investment Income Current Year1315173InvestmentIncomeCurrentYear
Other Revenue Prior Year-9853OtherRevenuePriorYear
Other Revenue Current Year-7191OtherRevenueCurrentYear
Total Revenue Prior Year3359771TotalRevenuePriorYear
Total Revenue Current Year4222024TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year497824GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY349477GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year1057637SalariesEtcPriorYear
Salaries Etc Current Year1178599SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year405962TotalFundrsngExpCurrentYear
Other Expense Prior Year748340OtherExpensePriorYear
Other Expenses Current Year1161985OtherExpensesCurrentYear
Total Expenses Prior Year2303801TotalExpensesPriorYear
Total Expenses Current Year2690061TotalExpensesCurrentYear
Revenues Less Expenses Prior Year1055970RevenuesLessExpensesPriorYear
Revenues Less Expenses CY1531963RevenuesLessExpensesCY
Total Assets BOY9832251TotalAssetsBOY
Total Assets EOY11482201TotalAssetsEOY
Total Liabilities BOY271704TotalLiabilitiesBOY
Total Liabilities EOY389691TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY9560547NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY11092510NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionTHE MISSION OF THE ASHP FOUNDATION IS TO IMPROVE THE HEALTH AND WELL-BEING OF PATIENTS IN HOSPITALS AND HEALTH SYSTEMS THROUGH APPROPRIATE, SAFE AND EFFECTIVE MEDICATION USE. THE FOUNDATION PROVIDES LEADERSHIP AND CONDUCTS EDUCATION AND RESEARCH ACTIVITIES THAT FOSTER THE COORDINATION OF INTERDISCIPLINARY MEDICATION MANAGEMENT LEADING TO OPTIMAL PATIENT OUTCOMES. EMPHASIS IS GIVEN TO PROGRAMS THAT WILL HAVE A MAJOR IMPACT ON ADVANCING PHARMACY PRACTICE IN HOSPITALS AND HEALTH SYSTEMS, THEREBY IMPROVING PUBLIC HEALTH.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense1102167Expense
Grants87172Grants
Revenue216540Revenue
DescriptionEXPANSION OF PHARMACISTS' DIRECT PATIENT CARE AND LEADERSHIP ROLES ASHP FOUNDATION RESEARCH ADVISORY PANEL-THE RESEARCH ADVISORY PANEL (RAP), CHAIRED BY DR. MICHAEL MILLER OF THE UNIVERSITY OF OKLAHOMA, MET IN PERSON AT THE ASHP MIDYEAR CLINICAL MEETING IN DECEMBER 2010 AND BY TELECONFERENCE THROUGHOUT THE YEAR. THE ASHP FOUNDATION VICE PRESIDENT WORKED CLOSELY WITH THE PANEL TO ESTABLISH RESEARCH PRIORITIES FOR THE PHARMACY PRACTICE MODEL INITIATIVE AND THE ASHP FOUNDATION'S NEW INVESTIGATOR RESEARCH GRANT PROGRAMS. IN ADDITION, THE RAP PROVIDED GUIDANCE ON REVISIONS TO THE LITERATURE AWARDS PROGRAM. CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP-THE CENTER WAS DEVELOPED AS A COLLABORATIVE PROGRAMMATIC OFFERING OF ASHP AND THE ASHP FOUNDATION, AND IS ADMINISTERED BY THE FOUNDATION. THE CENTER HAS BEEN IN OPERATION SINCE JANUARY 2007. ITS PRIMARY OBJECTIVES ARE TO: (1) ASSURE THAT PHARMACY LEADERS HAVE THE KNOWLEDGE NECESSARY TO PROACTIVELY INFLUENCE THE ADVANCEMENT OF THE MEDICATION-USE PROCESS BY PROVIDING COMPETENCY-BASED EDUCATION OPPORTUNITIES, (2) PROVIDE LEADERSHIP DEVELOPMENT PROGRAMS FOR STUDENTS, RESIDENTS AND NEW PRACTITIONERS THAT PROMOTE THE IMPORTANT ROLE OF THE PHARMACIST AS A CHANGE AGENT AND A LEADER IN PATIENT CARE, (3) INTEGRATE INTO HEALTH-SYSTEM LEADERSHIP DECISION-MAKING THE CRITICAL ROLE FOR PHARMACISTS AS ACTIVE PARTICIPANTS IN ACHIEVING ORGANIZATIONAL OBJECTIVES, (4) CONDUCT RESEARCH ON EFFECTIVE PHARMACY MANAGEMENT AND LEADERSHIP IN ACHIEVING THE OBJECTIVES OF HOSPITALS AND HEALTH SYSTEMS, AS WELL AS IMPROVING COMMUNITY DISEASE PREVENTION AND HEALTH PROMOTION EFFORTS AND (5) EXPLORE THE PURPOSE AND VALUE OF A CREDENTIAL FOR HOSPITAL AND HEALTH-SYSTEM PHARMACY LEADERS THAT RECOGNIZES COMPETENCIES TO DIRECT THE MEDICATION-USE SYSTEMS ENTERPRISE AND PROMOTE SAFETY AND COST-EFFECTIVE MEDICATION OUTCOMES. IN FY11 THE CENTER WAS ABLE TO COMPLETE OBJECTIVE #5 BY DETERMINING THAT AN ADDITIONAL CREDENTIAL IS NOT NEEDED FOR HEALTH-SYSTEM PHARMACY DIRECTORS/CHIEF PHARMACY OFFICERS. THE CENTER IS NOW EXPANDING OPPORTUNITIES FOR THESE LEADERS TO PURSUE MASTER'S DEGREES IN BUSINESS, HEALTH CARE ADMINISTRATION, INFORMATION MANAGEMENT AND PUBLIC HEALTH.THE CENTER ADVISORY PANEL (CAP)-THIS ADVISORY PANEL WAS ESTABLISHED IN FY08 AND IS A 12-MEMBER GROUP THAT HAS SERVED AS AN EXTERNAL RESOURCE OF EXPERTS PROVIDING AN ENVIRONMENTAL SCAN OF PRACTICE ISSUES AND SIGNIFICANT EVENTS THAT MIGHT AFFECT THE CENTER'S PLAN OF ACTION. THE CAP MET ONCE IN FY11 AND DETERMINED THAT ITS VALUE WAS OPTIMAL DURING THE INITIAL YEARS OF THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP. THE CAP OFFICIALLY DISBANDED AT THE END OF FY11, AND PROGRAMMATIC INPUT FOR THE CENTER WILL BE PROVIDED BY THE ASHP SECTION LEADERSHIP, COUNCILS AND COMMISSIONS.PHARMACY LEADERSHIP ACADEMY (PLA)-THE PLA IS SUPPORTED IN PART BY AN EDUCATIONAL GRANT FROM AMGEN. THE PLA IS DESIGNED TO PROVIDE ADDITIONAL COMPREHENSIVE TRAINING TO PHARMACY LEADERS BEYOND WHAT IS LEARNED IN PHARMACY RESIDENCIES, SHORT COURSES AND OTHER EDUCATIONAL PROGRAMS. THE ACADEMY PROVIDES LEADERSHIP TRAINING APPLICABLE TO CLINICAL AND ADMINISTRATIVE PHARMACY PRACTITIONERS IN SMALL TO LARGE HOSPITALS AND HEALTH SYSTEMS WHO ASPIRE TO LEADERSHIP POSITIONS IN HEALTH-SYSTEM PHARMACY. MOST IMPORTANTLY, THIS PROGRAM DIRECTLY BENEFITS PATIENTS BECAUSE PARTICIPANTS APPLY THEIR NEW-FOUND SKILLS IN THE HEALTH-SYSTEM ENVIRONMENT TO IMPROVE MEDICATION-USE SAFETY, QUALITY OF CARE AND USE OF HEALTH CARE RESOURCES. THE FOURTH CLASS BEGAN IN JANUARY 2011 WITH 83 PARTICIPANTS. MAJOR PROGRAM ENHANCEMENTS WERE ACHIEVED IN FY11 WHEN THE PLA CURRICULUM WAS UPGRADED, THE MODULES WERE EXPANDED TO 6 WEEKS, WERE SWITCHED TO THE ECOLLEGE LEARNING MANAGEMENT SYSTEM, AND THE PROGRAM PARTNERED WITH MASTERS DEGREE PROGRAMS IN HEALTH CARE ADMINISTRATION AT SIMMONS COLLEGE IN BOSTON AND NEW ENGLAND COLLEGE IN NEW HAMPSHIRE. THE 2011 CLASS INCLUDED FOUR INTERNATIONAL PARTICIPANTS, ONE FROM THE BAHAMAS AND THREE FROM LEBANON. THE 2012 APPLICATION CYCLE ENDED ON AUGUST 12, 2011.LEADERSHIP LEARNING COMMUNITY-THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP HOSTED A SUCCESSFUL LEARNING COMMUNITY AT THE JUNE 2011 ASHP SUMMER MEETING ENTITLED "WILL, IDEAS AND EXECUTION: STRATEGIES FOR SUSTAINED RESULTS AND UNPRECEDENTED PERFORMANCE." THE 5-SESSION SERIES OFFERED MORE THAN 11 HOURS OF MATERIAL AND HAD AN ESTEEMED FACULTY OF SENIOR PHARMACISTS AND HEALTH-SYSTEM EXECUTIVES FROM A VARIETY OF HEALTH-SYSTEM SETTINGS. EDUCATIONAL SESSIONS ADDRESSED THE PHARMACY LEADER'S ROLE IN MAKING THE STATUS QUO UNCOMFORTABLE, ENHANCING WORKING RELATIONSHIPS TO GET THE JOB DONE AND ENSURING THAT THE PATIENT IS AT THE CENTER OF THE CARE PROCESS. THE PROGRAM WAS EXTREMELY WELL RECEIVED, AND EACH SESSION WAS WELL ATTENDED.PHARMACY LEADERSHIP INSTITUTE (PLI)-SINCE 2008 THE SECTION FOR PHARMACY PRACTICE MANAGERS HAS COLLABORATED WITH BOSTON UNIVERSITY TO ESTABLISH THE PLI AS A MAJOR PROGRAM WITHIN THE CENTER'S PORTFOLIO AND TO HAVE IT SERVE AS ITS CAPSTONE PROGRAM. THE PLI USES RELEVANT PROGRAM CURRICULUM, HIGH-QUALITY INSTRUCTION AND PEER INTERACTION TO BROADEN BUSINESS SKILLS, MANAGERIAL VERSATILITY AND THE EXTRAORDINARY LEADERSHIP DEMANDED OF TODAY'S HEALTH-SYSTEM PHARMACY LEADERS. THE EXPERIENCE ENABLES PHARMACIST LEADERS TO DEVELOP A NEW WAY OF THINKING AND A NEW SET OF BEHAVIORS TO MEET THE DEMANDING CHALLENGES FACING PHARMACY. PLI GRADUATES HAVE BECOME A SOURCE OF LEADERSHIP EXPERTS SERVING THE CENTER'S INITIATIVES. THE CENTER, WORKING WITH THE SUPPORT OF THE CARDINAL HEALTH FOUNDATION AND EXPERTISE OF THE BOSTON UNIVERSITY SCHOOL OF MANAGEMENT, CONCLUDED THE TWELFTH PROGRAM OFFERING IN APRIL 2011. TWENTY-NINE (29) HEALTH-SYSTEM PHARMACY LEADERS WERE SELECTED TO ATTEND THE WEEK-LONG EXECUTIVE TRAINING PROGRAM AND THREE-HUNDRED TWENTY (320) PHARMACISTS HAVE PARTICIPATED IN THE PROGRAM SINCE ITS INCEPTION. CONVERSATIONS WITH HEALTH-SYSTEM PHARMACY'S MOST INFLUENTIAL LEADERS VIDEOS-ASHP PAST PRESIDENT AND WHITNEY AWARD RECIPIENT SARA WHITE PROVIDED THE FOUNDATION WITH ONGOING FINANCIAL SUPPORT AND VOLUNTEERED HER TIME TO HELP PRODUCE A SERIES OF VIDEOS WITH SOME OF THE MOST INFLUENTIAL HEALTH-SYSTEM PHARMACY LEADERS. THE VIDEOS ARE HOSTED ON THE ASHP FOUNDATION WEBSITE AS A LEADERSHIP RESOURCE AND A SOURCE OF MOTIVATION FOR HEALTH-SYSTEM PHARMACY PROFESSIONALS. THREE NEW VIDEOS WERE ADDED IN THE FALL OF 2010 (JOHN A. GANS, LUCINDA MAINS AND PAUL G. PIERPAOLI), EXPANDING THE TOTAL NUMBER OF VIDEOS TO 12. THREE NEW VIDEOS ARE PLANNED FOR COMPLETION IN FY12, AND ALL OF THE VIDEOS WILL BE MADE AVAILABLE AS PODCASTS.LEADERSHIP SPEAKERS BUREAU (LSB)- THE LSB IS THE FIRST PROGRAM OF THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP DEVELOPED SPECIFICALLY FOR STUDENTS. PHARMACISTS WHO ARE ASHP STATE AFFILIATE MEMBERS ARE THE PRIMARY SPEAKERS. THEY DRAW UPON THEIR PERSONAL AND PROFESSIONAL EXPERIENCES TO ENCOURAGE STUDENTS TO EMBRACE LEADERSHIP AS PART OF THEIR PROFESSIONAL OBLIGATION. SPEAKERS HIGHLIGHT LEADERSHIP OPPORTUNITIES AND PRACTICE SUCCESS STORIES IN HEALTH-SYSTEM PHARMACY TO UNDERSCORE THE NEED FOR THIS COMMITMENT AS STUDENTS. THE STUDENT FORUM LEADERSHIP SECTION ADVISORY GROUP HAS BECOME AN ACTIVE PARTNER IN THE LSB'S PROMOTION AND EVALUATION. THE LSB HAS BEEN TRANSFORMED INTO AN ONLINE TOOL KIT TO INCREASE ITS ACCESSIBILITY AND IS LINKED TO THE STUDENT FORUM WEB PAGE. SUPPORTED BY A GRANT FROM ROCHE, THE CENTER HAS SET A TARGET OF 30 SCHOOLS OF PHARMACY TO PARTICIPATE IN THE PROGRAM DURING FY12. OTHER PROGRAMS:- COMMUNITY HEALTH SYSTEMS (CHS) LEADERSHIP SEMINAR SERIES- LEADERSHIP RESOURCE CENTER- WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY- PGY-1 EXPANSION GRANT- STUDENT LEADERSHIP DEVELOPMENT WORKSHOP- PHARMACY STUDENT CLINICAL SKILLS COMPETITION- DEMONSTRATING PHARMACISTS' VALUE: A SYSTEMATIC EVIDENCE REVIEW- HARVEY A.K. WHITNEY AWARD LECTURE'S ONLINE COLLECTION PROGRAM- LITERATURE AWARDS PROGRAM- PHARMACY PRACTICE MODEL INITIATIVE (PPMI)- RESEARCH BOOT CAMP- STERILE PRODUCTS OUTSOURCING TOOL- ANTITHROMBOTIC ASSESSMENT TOOL- WALTER JONES MEMORIAL PHARMACY STUDENT FINANCIAL AID FUND AND THE ASHP STUDENT LEADERSHIP AWARDDescription

Activity2 Activity2

FieldValueIRS element (for citing)
Expense520548Expense
Grants128308Grants
DescriptionDESIGN AND STUDY OF SAFE AND EFFECTIVE MEDICATION-USE SYSTEMS:2010 AWARD FOR EXCELLENCE IN MEDICATION-USE SAFETY-SUPPORTED BY A GRANT FROM THE CARDINAL HEALTH FOUNDATION, THIS PROGRAM IS DESIGNED TO RECOGNIZE A PHARMACIST-LED MULTIDISCIPLINARY TEAM THAT MAKES SIGNIFICANT INSTITUTION-WIDE SYSTEM IMPROVEMENTS RELATING TO MEDICATION USE. THE PROGRAM IS IN ITS SEVENTH YEAR AND IS THE ONLY NATIONAL-LEVEL PROGRAM THAT RECOGNIZES THE PHARMACIST'S LEADERSHIP ROLE IN THE MEDICATION-USE PROCESS. THE THREE 2010 FINALIST ORGANIZATIONS WERE SELECTED FROM 16 APPLICANTS USING STRUCTURED SELECTION CRITERIA ESTABLISHED BY AN INDEPENDENT MULTIDISCIPLINARY PANEL OF EXPERTS IN THE FIELD OF MEDICATION SAFETY AND HEALTH-SYSTEM ADMINISTRATION. THE MEDICAL UNIVERSITY OF SOUTH CAROLINA IN CHARLESTON RECEIVED THE $50,000 AWARD. THE TWO FINALISTS, KINGSBROOK JEWISH MEDICAL CENTER IN BROOKLYN, N.Y., AND LANCASTER GENERAL HEALTH IN LANCASTER, PA., EACH RECEIVED $10,000. THE 2010 AWARD FOR EXCELLENCE VIDEO HIGHLIGHTED THE SUCCESS STORIES OF THE RECIPIENT AND FINALISTS AND WAS SHOWN TO MORE THAN 8,000 PHARMACISTS AT THE 2010 ASHP MIDYEAR CLINICAL MEETING OPENING GENERAL SESSION IN ANAHEIM, CALIF. A DINNER WAS ALSO HELD AT THE MIDYEAR TO RECOGNIZE THE FINALIST AND RECIPIENT TEAMS.THE MEDICAL UNIVERSITY OF SOUTH CAROLINA (MUSC) MEDICAL CENTER'S AWARD WINNING MEDICATION SAFETY INITIATIVE FOCUSED ON OPTIMIZING MEDICATION USE AND OUTCOMES IN KIDNEY TRANSPLANT PATIENTS. OVER AN 18-MONTH PERIOD, MUSC IMPLEMENTED A MULTISTEP INITIATIVE TO DECREASE HOSPITAL LENGTH OF STAY AND PREVENTABLE READMISSIONS FOR THESE PATIENTS WHILE OPTIMIZING PATIENT AND TRANSPLANTED ORGAN OUTCOMES. THEY REVISED KIDNEY TRANSPLANT PROTOCOLS, ESTABLISHED A DIABETES MANAGEMENT SERVICE TO MANAGE INPATIENT AND OUTPATIENT GLUCOSE CONTROL AND IMPLEMENTED INTENSIVE PATIENT AND CAREGIVER EDUCATION BEFORE AND AFTER DISCHARGE. THEY ALSO DEVELOPED A NEW PROCESS TO RECONCILE MEDICATIONS USED BEFORE AND AFTER TRANSPLANT AND STREAMLINED THE WAY THEY PROVIDE HOME MEDICATIONS TO PATIENTS. AS A RESULT, MUSC EXPERIENCED A 40-PERCENT REDUCTION IN MEDICATION ERRORS AND ADVERSE DRUG EVENTS, A 25-PERCENT REDUCTION IN ACUTE REJECTION RATES AND A 10-PERCENT DECREASE IN INFECTION RATES. MUSC ALSO REDUCED DELAYED DISCHARGES BY 14 PERCENT AND 7-DAY READMISSION RATES BY 50 PERCENT. MUSC'S INITIATIVE DEMONSTRATES THAT A SYSTEMATIC AND TEAM-BASED QUALITY IMPROVEMENT PROCESS FOCUSED ON A HIGH-RISK PATIENT POPULATION CAN IMPROVE QUALITY OF CARE AND PATIENT OUTCOMES.FOR THE FOURTH YEAR, THE ASHP FOUNDATION, WITH ASSISTANCE FROM ASHP, SPONSORED A NATIONAL RADIO MEDIA TOUR AIMED AT EDUCATING CONSUMERS ABOUT THE VITAL ROLE OF HEALTH-SYSTEM PHARMACISTS. THE RADIO MEDIA TOUR OCCURRED IN MARCH 2011 DURING NATIONAL PATIENT SAFETY AWARENESS WEEK. FOR THE TOUR, THERE WERE 19 TAPED AND LIVE INTERVIEWS, WHICH REACHED 576,000 LISTENERS. DR. NICOLE PILCH ALSO TAPED A RADIO NEWS RELEASE FOR NATIONAL PATIENT SAFETY AWARENESS WEEK THAT WAS AIRED BY APPROXIMATELY 779 STATIONS AND WAS HEARD BY 2.7 MILLION LISTENERS. IN ADDITION, DRS. PILCH AND DAVID TABER PRESENTED AN EDUCATIONAL SESSION AT THE 2011 ASHP SUMMER MEETING ENTITLED "MEDICATION SAFETY IN A HIGH-RISK PATIENT POPULATION: THE MUSC STORY."THE 2011 AWARD PROGRAM WAS LAUNCHED IN EARLY SPRING WITH PROMOTION TO HEALTH SYSTEMS ACROSS THE COUNTRY. FORTY-EIGHT APPLICATIONS WERE RECEIVED FOR THE 2011 PROGRAM. THE AWARD RECIPIENT AND FINALISTS WILL BE SELECTED IN AUGUST 2011.MEDICATION SAFETY TEAM GRANT: OPTIMIZING BEDSIDE TECHNOLOGY SOLUTIONS-THE THREE-YEAR COMMITMENT FROM OMNICELL TO SUPPORT THIS PROGRAM ENDED IN MAY 2009. RESEARCH BY THE 2009 RECIPIENTS IS ONGOING. DRS. ASHLEY DALTON, CRAIG FROST AND STEVEN ABEL PRESENTED THEIR FINDINGS AT THE 2010 ASHP MIDYEAR CLINICAL MEETING IN A SESSION ENTITLED "RESULTS FROM BCMA RESEARCH: A TALE OF THREE CITIES." DR. FROST'S STUDY, ENTITLED "EFFECT OF BAR-CODE-ASSISTED MEDICATION ADMINISTRATION ON NURSES' ACTIVITIES IN AN INTENSIVE CARE UNIT: A TIME-MOTION STUDY," WAS PUBLISHED IN THE AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. (SEE: DWIBEDI N, SANSGIRY SS, FROST CP, DASGUPTA A, JACOB SM, TIPTON JA, SHIPPY AA. EFFECT OF BAR-CODE-ASSISTED MEDICATION ADMINISTRATION ON NURSES' ACTIVITIES IN AN INTENSIVE CARE UNIT: A TIME-MOTION STUDY. AM J HEALTH SYST PHARM. 2011 JUN 1;68(11):1026-31.)THE OTHER GRANT RECIPIENTS FROM 2007 AND 2008 ARE PREPARING MANUSCRIPTS FOR PUBLICATION. MEDICATION CONTINUITY OF CARE RECORD RESEARCH (ALSO SUPPORTS STRATEGIC PRIORITY SP 2)-THIS PROGRAM EVALUATION ENTITLED "DEVELOPMENT OF A CONTINUITY OF CARE RECORD: BRIDGING THE MEDICATION-USE GAP FROM HOSPITAL TO HOME," IS BEING CONDUCTED BY KIM C. COLEY, PHARM.D., OF THE UNIVERSITY OF PITTSBURGH SCHOOL OF PHARMACY. THIS STUDY IS SUPPORTED BY SANOFI AVENTIS. DR. COLEY IS STUDYING THE USE OF A CONTINUITY OF CARE RECORD AND MEDICATION THERAPY MANAGEMENT IN THE TRANSITION OF PATIENTS FROM HOSPITAL TO HOME. PREPARATION OF THE FIRST TWO MANUSCRIPTS FROM THIS STUDY, A REPORT ON THE TOOL DEVELOPMENT AND A HYPOTHESIS-GENERATING CASE SERIES, IS UNDERWAY. THIS STUDY IS BEING MODIFIED TO INCLUDE A FOCUS GROUP COMPONENT THAT WILL BE USED TO ENHANCE THE CONTINUITY OF CARE TOOL.PANDEMIC INFLUENZA ASSESSMENT TOOL (ALSO SUPPORTS SP 2 AND 3)-ROCHE PROVIDED A GRANT TO DEVELOP A PANDEMIC READINESS AND EMERGENCY PREPAREDNESS RESOURCE CENTER WHICH IS AVAILABLE AT WWW.PHARMACYREADY.ORG. THIS SITE CONTAINS THE PANDEMIC INFLUENZA ASSESSMENT TOOL FOR HEALTH-SYSTEM PHARMACY DEPARTMENTS (TM) ALONG WITH PRACTICE RESOURCES, RSS FEEDS AND BENCHMARKING DATA. BETWEEN JUNE 2009 AND MAY 2010, DURING AN H1N1 INFLUENZA PANDEMIC, THERE WERE MORE THAN 150,000 VISITS TO THIS WEB-BASED TOOL. THE TOOL CONTINUES TO BE USED DESPITE THE ABSENCE OF A CURRENT PANDEMIC INFLUENZA THREAT. THIS RESOURCE CONTINUES TO RECEIVE A SUBSTANTIAL NUMBER OF VISITORS ON A MONTHLY BASIS.Description

Activity3 Activity3

FieldValueIRS element (for citing)
Expense478824Expense
Grants133997Grants
DescriptionADVANCEMENT OF OPTIMAL PATIENT MEDICATION OUTCOMES:ASHP FDTN JUNIOR INVESTIGATOR RESEARCH GRANT (ALSO SUPPORTS SP 3)-EIGHTEEN APPLICATIONS WERE RECEIVED FOR THE ASHP FOUNDATION JUNIOR INVESTIGATOR RESEARCH GRANT DURING THE FY11 CYCLE. THIS GRANT IS OFFERED TO NEW PHARMACIST INVESTIGATORS AND IS INTENDED TO SUPPORT PRACTICE-BASED MEDICATION-USE RESEARCH. GRANT FUNDS ARE PROVIDED BY THE ASHP FOUNDATION THROUGH JOSEPH A. ODDIS ENDOWMENT. A SEVEN-MEMBER REVIEW PANEL COMPOSED OF PHARMACIST AND PHYSICIAN RESEARCHERS RECOMMENDED AWARD OF THE FOLLOWING GRANTS: "PHARMACODYNAMIC ANALYSIS OF VANCOMYCIN BASED ON PATIENT-SPECIFIC PROTEIN BINDING," WHICH WILL BE CONDUCTED BY JARED L. CRANDON, PHARM.D., AND DAVID P. NICOLAU, PHARM.D., OF HARTFORD HOSPITAL AND "COMPARISON OF IMMUNE RESPONSE TO THE INFLUENZA VACCINE IN OBESE AND NON-OBESE HEALTHCARE WORKERS," WHICH WILL BE CONDUCTED BY MICHAEL A. SWEET, PHARM.D., OF WEST VIRGINIA UNIVERSITY HOSPITALS, AND RASHIDA A. KHAKOO, M.D., OF THE WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE. STUDIES FUNDED DURING THE FY09 AND FY10 GRANT CYCLES PROGRESSED DURING FY11. 2009 RECIPIENT DR. LETICIA MOCZYGEMBA RECEIVED THE 2011 BEST NEW INVESTIGATOR PODIUM RESEARCH PRESENTATION AWARD FROM THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH (ISPOR) FOR PRESENTATION OF HER STUDY ENTITLED "12-MONTH OUTCOMES OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY." RESEARCH FROM THE 2010 PROGRAM IS ONGOING. AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP- THE ASHP FOUNDATION PARTNERED WITH ASHP TO SUPPORT ANNUAL FUNDING OF $7,500 FOR THE 2010 AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. THE ASHP/ASHP FOUNDATION SCHOLARSHIP WAS AWARDED TO DEANNA S. FLORA, A PH.D. CANDIDATE IN CLINICAL PHARMACEUTICAL SCIENCE AT VIRGINIA COMMONWEALTH UNIVERSITY COLLEGE OF PHARMACY. HER DISSERTATION TOPIC IS "DRUG BURDEN AND COGNITION IN COMMUNITY-DWELLING OLDER ADULTS."ANTITHROMBOTIC PHARMACOTHERAPY TRAINEESHIP PROGRAM-IN COLLABORATION WITH ASHP AS PART OF A MULTI TIERED EDUCATIONAL PROGRAM, THE FOUNDATION RECEIVED FUNDING FOR THE 2009/2010 ANTITHROMBOTIC PHARMACOTHERAPY TRAINEESHIP FROM SANOFI-AVENTIS. THE 2009/2010 PROGRAM OFFERING WAS REVISED TO INCLUDE A COMPREHENSIVE WEB-BASED DISTANCE EDUCATION PROGRAM AND COMPARISON OF ANTITHROMBOTIC MEDICATION-RELATED PRE/POST-PROCESS AND PATIENT OUTCOMES. THE TRAINEESHIP CONCLUDED WITH A 5-DAY STRUCTURED EXPERIENTIAL PROGRAM THAT PREPARED PHARMACISTS TO ESTABLISH AND MAINTAIN SPECIALIZED SERVICES FOR THE MANAGEMENT OF PATIENTS' ANTITHROMBOTIC THERAPY. TWENTY-NINE TRAINEES WERE SELECTED FROM 31 APPLICANTS FOR THE 2009 PROGRAM, WITH 11 TRAINEES PARTICIPATING IN SESSION I AND 18 PARTICIPATING IN SESSION II. THE ASHP FOUNDATION TRACKED PROCESS AND PATIENT POPULATION OUTCOMES FOR EACH TRAINEE OVER A 1-YEAR PERIOD OF TIME. POSITIVE PATIENT CARE AND PROCESS EFFECTS WERE OBSERVED IN ESTABLISHMENT OF SERVICES IN THE INPATIENT AND OUTPATIENT SETTING. CRITICAL CARE TRAINEESHIP PROGRAM- PLANS ARE UNDERWAY TO ESTABLISH AN EXPERT PANEL TO REVISE THE CURRICULUM FOR THIS TRAINEESHIP IN EARLY WINTER 2011. THIS TRAINEESHIP WILL BE CONSIDERED FOR INCLUSION IN THE TUITION-BASED TRAINEESHIP MODEL THAT IS CURRENTLY BEING CONSIDERED. FEDERAL SERVICES JUNIOR INVESTIGATOR GRANT PROGRAM: OPTIMIZING CHRONIC DRUG THERAPY IN THE ELDERLY-FOUR APPLICATIONS WERE RECEIVED FOR THE ASHP FOUNDATION FEDERAL SERVICES JUNIOR INVESTIGATOR GRANT PROGRAM DURING THE MOST RECENT CYCLE. THIS GRANT IS OFFERED TO NEW PHARMACIST INVESTIGATORS AND IS INTENDED TO SUPPORT PRACTICE-BASED RESEARCH THAT FOCUSES ON OPTIMIZATION OF CHRONIC MEDICATION USE IN PATIENTS GREATER THAN 60 YEARS OF AGE. GRANT FUNDS ARE PROVIDED BY THE ASHP FOUNDATION THROUGH THE SUPPORT OF NOVARTIS. A FOUR-MEMBER REVIEW PANEL COMPOSED OF PHARMACIST AND PHYSICIAN RESEARCHERS RECOMMENDED AWARD OF THE FOLLOWING GRANTS: "EFFECT OF VIDEO-CONSULTATION ON MEDICATION ADHERENCE AND CLINICAL HEALTH OUTCOMES IN ELDERLY ALASKA NATIVES AND AMERICAN INDIANS IN RURAL ALASKA," WHICH WILL BE CONDUCTED BY SARA DORAN-ATCHISON, PHARM.D., OF THE ALASKAN NATIVE TRIBAL HEALTH CONSORTIUM, AND RENEE ROBISON, PHARM.D., OF THE SOUTHCENTRAL FOUNDATION; "A PILOT STUDY TO EVALUATE A TELEPHARMACY INTERVENTION TO IMPROVE INHALER ADHERENCE IN VETERANS WITH COPD," WHICH WILL BE CONDUCTED BY AMANDA R. MARGOLIS, PHARM.D., AND CHRISTINE SORKNESS, PHARM.D. OF THE UW-MADISON SCHOOL OF PHARMACY AND "A PROSPECTIVE EVALUATION OF A MEDICATION THERAPY MANAGEMENT CLINIC VERSUS USUAL MEDICAL CARE IN PATIENTS POST ACUTE CORONARY SYNDROME: THE MUMPS STUDY" WHICH WILL BE CONDUCTED BY CASSANDRA D. BENGE, PHARM.D., AND JAMES ANTHONY S. MULDOWNEY, M.D., OF TENNESSEE VALLEY HEALTH CARE SYSTEM PHARMACY. RESEARCH FUNDED DURING THE FY08 AND FY09 CYCLES CONTINUES TO BE ONGOING.2007 RECIPIENT, DR. KRISTEN SCHMITT OF THE CINCINNATI VA MEDICAL CENTER AND UNIVERSITY OF CINCINNATI COLLEGE OF PHARMACY, PUBLISHED HER RESEARCH REGARDING THE USE OF ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE. (SEE: SCHMITT KE, EDIE CF, LAFLAM P, SIMBARTL LA, THAKAR CV. ADHERENCE TO ANTIHYPERTENSIVE AGENTS AND BLOOD PRESSURE CONTROL IN CHRONIC KIDNEY DISEASE. AM J NEPHROL. 2010;32(6):541-8. EPUB 2010 NOV 2.)HOSPITAL PHARMACIST - HOSPITALIST COLLABORATIONS (ALSO SUPPORTS SP 3)-SANOFI-AVENTIS PROVIDED SPONSORSHIP FOR THIS PROGRAM THAT STUDIES MULTIDISCIPLINARY INITIATIVES BETWEEN HOSPITALISTS AND HOSPITAL PHARMACISTS FOCUSED ON VENOUS THROMBOEMBOLISM PREVENTION/TREATMENT OR GLYCEMIC CONTROL IN HOSPITALIZED PATIENTS. DRS. JEFFREY KETZ OF THE CLEVELAND CLINIC AND DR. KEVIN BOX OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO PRESENTED THEIR RESEARCH FINDINGS IN A JOINT SESSION AT THE 2010 ASHP MIDYEAR CLINICAL MEETING. DR. KETZ ALSO PRESENTED HIS RESEARCH AT THE 2011 SOCIETY FOR HOSPITAL MEDICINE ANNUAL MEETING. EMERGENCY PHYSICIAN/HOSPITAL PHARMACIST RESEARCH GRANT PROGRAM (ALSO SUPPORTS SP 3)-ORTHO-MCNEIL PROVIDED SPONSORSHIP FOR THIS PROGRAM WHICH SUPPORTS RESEARCH CONDUCTED BY HOSPITAL PHARMACISTS AND EMERGENCY PHYSICIANS RELATED TO THE CARE OF PATIENTS WITH INFECTIOUS DISEASES WHO PRESENT TO THE EMERGENCY DEPARTMENT. A 10-MEMBER REVIEW PANEL COMPOSED OF PHARMACISTS AND EMERGENCY PHYSICIANS RECOMMENDED AWARD OF THE FOLLOWING GRANTS: "ED PHARMACISTS OPTIMIZE ANTIMICROBIAL USE PROCESS IN SEVERE SEPSIS AND SEPTIC SHOCK," WHICH WILL BE CONDUCTED BY MARIA I. RUDIS, PHARM.D., AND CHRISTOPHER S. RUSSI, D.O., OF MAYO CLINIC ROCHESTER; "THE VALUE OF MRSA NARES CARRIAGE STATUS FOR TREATMENT OF SKIN AND SOFT INFECTIONS IN THE EMERGENCY DEPARTMENT," WHICH WILL BE CONDUCTED BY NICOLE M. ACQUISTO, PHARM.D., AND SHARON G. HUMISTON, M.D., M.P.H., OF THE UNIVERSITY OF ROCHESTER MEDICAL CENTER. THE PROPOSED RESEARCH IS ONGOING AS SCHEDULED AT THE RESPECTIVE SITES. ONCOLOGY PATIENT CARE TRAINEESHIP PROGRAM-SUPPORT FOR THE 2011 PROGRAM WAS PROVIDED BY AMGEN. EIGHT TRAINEES WERE SELECTED FROM 33 APPLICANTS. DISTANCE EDUCATION COMMENCED IN FEBRUARY 2011. PARTICIPANTS WILL RECEIVE THEIR EXPERIENTIAL TRAINING AT THE FOLLOWING THREE SITES BETWEEN AUGUST AND NOVEMBER 2011: THE JOHNS HOPKINS HOSPITAL, UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER, AND THE UNIVERSITY OF WASHINGTON MEDICAL CENTER. PAIN AND PALLIATIVE CARE TRAINEESHIP PROGRAM-ENDO PHARMACEUTICALS PROVIDED SUPPORT FOR A REDESIGN OF THE FORMER PAIN MANAGEMENT TRAINEESHIP TO INCLUDE PALLIATIVE CARE AND TO TRANSFORM THE DISTANCE EDUCATION COMPONENT TO REACH MORE PHARMACISTS. THE DISTANCE EDUCATION PROGRAM WILL INCLUDE A PAIN MANAGEMENT AND PALLIATIVE CARE SELF-ASSESSMENT TOOL AND MODULES TO ADDRESS APPLICATION OF THE PRINCIPLES OF PAIN MANAGEMENT AND PALLIATIVE CARE. DR. MARY LYNN MCPHERSON OF THE UNIVERSITY OF MARYLAND HAS BEEN ENGAGED TO SUPPORT THE CONTENT REDESIGN. ADDITIONAL FACULTY HAS BEEN RECRUITED FOR LEVEL 2. DEVELOPMENT OF CONTENT FOR LEVELS 1 AND 2 WAS ONGOING FROM OCTOBER 2010 THROUGH MAY 2011. FOLLOWING REDESIGN, TEN INDIVIDUALS WHO COMPLETE THE DISTANCE EDUCATION COMPONENTS WILL BE SELECTED TO PARTICIPATE IN ONSITE TRAINING AT FIVE HEALTH SYSTEMS ACROSS THE U.S.OTHER PROGRAMS:- PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM- PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM- PROMOTING INFLUENZA PREVENTION: PHARMACISTS AS IMMUNIZATION ADVOCATES- MULTICENTER MEDICATION RECONCILIATION QUALITY IMPROVEMENT STUDY (MARQUIS)- UNIVERSITY OF ALABAMA MUSCULOSKELETAL CERTS- MULTISITE UNSOLICITED GRANTDescription
FieldValueIRS element (for citing)
Total Program Service Expense2101539TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities0LobbyingActivities
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments1TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities0ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities1FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals1GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions1DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org1TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With109687NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees0NumberOfEmployees
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions1QuidProQuoContributions
Quid Pro Quo Disclosure1QuidProQuoDisclosure
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members10NbrVotingGoverningBodyMembers
Number Independent Voting Members8NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees0MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other0CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledMDStatesWhereCopyOfReturnIsFiled
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1ELIZABETH HARTNETTBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number3016648612TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (15 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationHighest Compensated EmployeeHighestCompensatedEmployee
KEVIN J COLGAN MA FASHP
CHAIR1.00XX000
DAVID R GAUGH
VICE CHAIR1.00XX000
HENRI R MANASSE JR PHD SCD
PRESIDENT/ASHP EVP-CEO1.00XX074615476276
PHILIP J SCHNEIDER BS PHARMD
TREASURER1.00XX000
STEPHEN J ALLEN MS FASHP
SECRETARY/EVP-CEO40.00XX240214030422
BARBARA BALIK RN MS EDD
DIRECTOR AT LARGE1.00X000
MICK L HUNT MS MBA FASHP
DIRECTOR AT LARGE1.00X000
MICHAEL S FLAGSTAD MS RPH
DIRECTOR AT LARGE1.00X000
LYNNAE M MAHANEY MBA FASHP
DIRECTOR AT LARGE1.00X0100000
BRUCE E SCOTT PHARMD FASHP
DIRECTOR AT LARGE1.00X000
DALLAS J HOWE
DIRECTOR AT LARGE1.00X000
GORDON S WILLCOX
DIRECTOR AT LARGE1.00X000
DANIEL COBAUGH
VICE PRESIDENT40.00161174022820X
RICHARD WALLING
DIRECTOR, CTR FOR HLTH-SYS PHARM LDRSHP40.00148484012973X
MYRNA KONAJESKI
DIRECTOR OF DEVELOPMENT40.00106899021441X
FieldValueIRS element (for citing)
Total Reportable Comp From Org656771TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs756154TotalReportableCompFrmRltdOrgs
Total Other Compensation163932TotalOtherCompensation
Number Individuals GT100 K4NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation

Name Of Contractor NameOfContractor

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1ENVISION CHANGE LLCBusinessNameLine1

Address Of Contractor AddressOfContractor

Address US AddressUS

FieldValueIRS element (for citing)
Address Line13324D WEST CARY STREETAddressLine1
CityRICHMONDCity
StateVAState
ZIP Code23221ZIPCode
FieldValueIRS element (for citing)
Description Of ServicesCONSULTINGDescriptionOfServices
Compensation111483Compensation
FieldValueIRS element (for citing)
Number Of Contractors GT100 K1NumberOfContractorsGT100K
Fundraising Events27315FundraisingEvents
All Other Contributions2670187AllOtherContributions
Total Contributions2697502TotalContributions

Program Service Revenue ProgramServiceRevenue

FieldValueIRS element (for citing)
DescriptionPHARMACY LEADERSHIP ACDescription
Business Code900099BusinessCode
Total Revenue Column216540TotalRevenueColumn
Related Or Exempt Function Income216540RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue216540TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column232970TotalRevenueColumn
Exclusion$232,970ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities1095594Securities
Other47409Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Other60800Other

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities1095594Securities
Other-13391Other

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column1082203TotalRevenueColumn
Exclusion$1,082,203ExclusionAmount
FieldValueIRS element (for citing)
Gross Income Fundraising Events7085GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events27315CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses14276FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column-7191TotalRevenueColumn
Exclusion-$7,191ExclusionAmount

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column4222024TotalRevenueColumn
Related Or Exempt Function Income216540RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$1,307,982ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total269944Total
Program Services269944ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total79533Total
Program Services79533ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total275172Total
Program Services189739ProgramServices
Management And General11264ManagementAndGeneral
Fundraising74169Fundraising

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total730698Total
Program Services501090ProgramServices
Management And General26523ManagementAndGeneral
Fundraising203085Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total73975Total
Program Services49751ProgramServices
Management And General5764ManagementAndGeneral
Fundraising18460Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total45214Total
Program Services27377ProgramServices
Management And General2398ManagementAndGeneral
Fundraising15439Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total53540Total
Program Services43494ProgramServices
Management And General3956ManagementAndGeneral
Fundraising6090Fundraising

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total9600Total
Management And General9600ManagementAndGeneral

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total634990Total
Program Services539920ProgramServices
Management And General62057ManagementAndGeneral
Fundraising33013Fundraising

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total15056Total
Program Services9812ProgramServices
Management And General1330ManagementAndGeneral
Fundraising3914Fundraising

Occupancy Occupancy

FieldValueIRS element (for citing)
Total59691Total
Program Services32851ProgramServices
Management And General12509ManagementAndGeneral
Fundraising14331Fundraising

Travel Travel

FieldValueIRS element (for citing)
Total263690Total
Program Services233471ProgramServices
Management And General27349ManagementAndGeneral
Fundraising2870Fundraising

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total24806Total
Program Services14263ProgramServices
Management And General10543ManagementAndGeneral

Other Expenses OtherExpenses (5 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
GENERAL EXPENSES146543115471333127741
TEMPORARY SERVICES17600880026406160
BANK CHARGES24732473
STAFF DEVELOPMENT1812299823690
SPECIAL EVENT EXPENSE T-14276-14276

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total2690061Total
Program Services2101539ProgramServices
Management And General182560ManagementAndGeneral
Fundraising405962Fundraising

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY1019149BOY
EOY2073427EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY214572BOY
EOY197662EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY9325BOY
EOY1847EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis136358LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec107479LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY65332BOY
EOY28879EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY8377415BOY
EOY9058798EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY146458BOY
EOY121588EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY9832251BOY
EOY11482201EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY194520BOY
EOY182577EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY77184BOY
EOY152829EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY0BOY
EOY54285EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY271704BOY
EOY389691EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY1869549BOY
EOY2060723EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY2912954BOY
EOY4253393EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY4778044BOY
EOY4778394EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY9560547BOY
EOY11092510EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY9832251BOY
EOY11482201EOY
FieldValueIRS element (for citing)
Reconcilation Revenue Expenses1531963ReconcilationRevenueExpenses
Reconcilation Other Changes0ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee0AuditCommittee
Financial Statement SeparateXFinancialStatementSeparate
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org170b1 AviXPubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1606236CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years1802114CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years1610656CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year1993575CurrentTaxYearMinus1Year
Current Tax Year2697502CurrentTaxYear
Total9710083Total

Total170 Total170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1606236CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years1802114CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years1610656CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year1993575CurrentTaxYearMinus1Year
Current Tax Year2697502CurrentTaxYear
Total9710083Total
FieldValueIRS element (for citing)
Amounts Subst Contributors Total4658390AmountsSubstContributorsTotal
Public Support Total1705051693PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years357682CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years307359CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years299628CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year234578CurrentTaxYearMinus1Year
Current Tax Year232970CurrentTaxYear
Total1432217Total

Other Income170 OtherIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years36582CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years6720CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years9285CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year8760CurrentTaxYearMinus1Year
Current Tax Year7085CurrentTaxYear
Total68432Total
FieldValueIRS element (for citing)
Total Support11210732TotalSupport
Gross Receipts From Admissions Etc567862GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage1700.45060PublicSupportPertcentage170
Public Support Pertcent Prior Year0.44450PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170XThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule D IRS990ScheduleD

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance5934328BeginningOfYearBalance
Contributions350Contributions
Investment Earnings Or Losses886373InvestmentEarningsOrLosses
Other Expenditures539855OtherExpenditures
End Of Year Balance6281196EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance5554292BeginningOfYearBalance
Contributions7295Contributions
Investment Earnings Or Losses899095InvestmentEarningsOrLosses
Other Expenditures526354OtherExpenditures
End Of Year Balance5934328EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

FieldValueIRS element (for citing)
Beginning Of Year Balance6505305BeginningOfYearBalance
Contributions900Contributions
Investment Earnings Or Losses-1659001InvestmentEarningsOrLosses
Other Expenditures-707088OtherExpenditures
End Of Year Balance5554292EndOfYearBalance
FieldValueIRS element (for citing)
Board Designated EOY Balance0.07960BoardDesignatedEOYBalance
Permanent Endowment EOY Balance0.76070PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.15970TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs0EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs0EndowmentsHeldByRelatedOrgs

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis136358OtherCostOrOtherBasis
Depreciation107479Depreciation
Book Value28879BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings28879TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
DescriptionDUE TO ASHPDescription
Amount$54,285Amount
FieldValueIRS element (for citing)
Total Of Amounts54285TotalOfAmounts
Total Revenue4222024TotalRevenue
Total Expenses2690061TotalExpenses
Excess Or Deficit For Year1531963ExcessOrDeficitForYear
Total Adjustments0TotalAdjustments
Excess Or Deficit Per FS1531963ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt4289014TotRevenueEtcAuditedFinclStmt
Donated Srvc And Use Of Facilities39323DonatedSrvcAndUseOfFacilities
Other Revenues27667OtherRevenues
Revenue Not Rptd F99066990RevenueNotRptdF990
Revenue Subtotal4222024RevenueSubtotal
Revenue Not Rptd On Fin Stmt0RevenueNotRptdOnFinStmt
Total Revenue Per Form9904222024TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt2757051TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities39323DonatedServicesUseOfFacilities
Other Expenses Included27667OtherExpensesIncluded
Expenses Not Rptd F99066990ExpensesNotRptdF990
Expenses Subtotal2690061ExpensesSubtotal
Expenses Not Rptd On Fin Stmt0ExpensesNotRptdOnFinStmt
Total Expenses Per Form9902690061TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:PART V, LINE 4:THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH WAS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:PART X:DURING THE YEAR ENDED MAY 31, 2011, MANAGEMENT DID NOT IDENTIFY ANY UNCERTAIN INCOME TAX POSITIONS. AT A MINIMUM, THE TAX YEARS BEGINNING IN 2007 THROUGH 2010 ARE OPEN FOR EXAMINATION BY TAX AUTHORITIES.
PART XII, LINE 2D - OTHER ADJUSTMENTS:LOSS ON DISPOSITION OF ASSETS 13,391. SPECIAL EVENTS DIRECT EXPENSES 14,276.
PART XIII, LINE 2D - OTHER ADJUSTMENTS:LOSS ON DISPOSITION OF ASSETS 13,391. SPECIAL EVENTS DIRECT EXPENSES 14,276.

Schedule G IRS990ScheduleG

Events Information EventsInformation

FieldValueIRS element (for citing)
Name Of Event1WALTER JONES GOLF CLASSICNameOfEvent1
Gross Receipts Event134400GrossReceiptsEvent1
Charitable Contributions Event127315CharitableContributionsEvent1
Gross Revenue Event17085GrossRevenueEvent1
Non Cash Prizes Event1853NonCashPrizesEvent1
Rent Facility Costs Event14192RentFacilityCostsEvent1
Food And Beverage Event14669FoodAndBeverageEvent1
Other Direct Expenses Event14562OtherDirectExpensesEvent1
Gross Receipts Total34400GrossReceiptsTotal
Charitable Contributions Total27315CharitableContributionsTotal
Gross Revenue Total Events7085GrossRevenueTotalEvents
Non Cash Prizes Total Events853NonCashPrizesTotalEvents
Rent Facility Costs Total Events4192RentFacilityCostsTotalEvents
Food And Beverage Total Events4669FoodAndBeverageTotalEvents
Other Direct Expenses Total Events4562OtherDirectExpensesTotalEvents
Direct Expense Summary Events14276DirectExpenseSummaryEvents
Net Income Summary-7191NetIncomeSummary

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (27 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrant
ALLINA HOSPITALS AND CLINICS
PO BOX 43MINNEAPOLISMN55440363261413501(C)(3)129102009 MEDICATION SAFETY GRANT
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
7272 WISCONSIN AVEBETHESDAMD20814520807628501(C)(6)24766CLINICAL SKILLS COMPETITION GRANT
AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION
1 CHURCH ST STE 202ROCKVILLEMD20850530214882501(C)(3)5000PRE-DOCTORAL FELLOWSHIP
ARIZONA BOARD OF REGENTS
PO BOX 3308TUCSONAZ857223308860779656501(C)(3)50002010 PHARMACY RESIDENT PRACTICAL GRANT
BOARD OF REGENTS UNIV OF WISCONSIN
1220 LINDEN DRMADISONWI53706396006492501(C)(3)6406FEDERAL SERVICES RESEARCH GRANT
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115042312909501(C)(3)66052010 JR INVESTING RESEARCH GRANT
DUKE UNIVERSITY MEDICAL CENTER
2301 ERWIN ROADDURHAMNC27705562070036501(C)(3)5000ONCOLOGY TRAINEESHIP
KAISER FOUNDATION HEALTH PLAN OF COLORADO
16601 E CENTRETECH PKWYAURORACO800119045840591617501(C)(3)65202010 JR INVEST GRANT
KAISER FOUNDATION HEALTH PLAN OF GEORGIA INC
ONE KAISER PLAZA STE 15LOAKLANDCA94612581592076501(C)(3)50002010 PHARMACY RESIDENT PRACTICAL GRANT
KINGSBROOK JEWISH MEDICAL CENTER
585 SCHENECTADY AVEBROOKLYNNY11203111631759501(C)(3)100002010 AWARD FOR EXCELLENCE
LANCASTER GENERAL HOSPITAL
PO BOX 3555LANCASTERPA17604231365353501(C)(3)100002010 AWARD FOR EXCELLENCE
MASSACHUSETTS COLLEGE OF PHARMACY
179 LONGWOOD AVEBOSTONMA02115042104700501(C)(3)83332009 JR INVEST GRANT
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905416011702501(C)(3)165002009 EMERGENCY CARE GRANT
MEDICAL UNIVERSITY HOSPITAL AUTHORITY
169 ASHLEY AVE STE 203CHARLESTONSC29403571098556501(C)(3)500002010 AWARD FOR EXCELLENCE
SAINT LUKE'S EPISCOPAL HOSPITAL
6720 BERTNERHOUSTONTX77030741161938501(C)(3)136002008 MEDICATION SAFETY
TENNESSEE VALLEY HEALTH CARE SYSTEMMIDDLE TENN RES INSTITUTE
1310 24TH AVE SNASHVILLETN37212741161938501(C)(3)76192010 FEDERAL SERVICES JR. INVESTIGATOR GRANT
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
506 S WRIGHT STREET 209 HAB MC 339URBANAIL61801376000511501(C)(3)50002010 PHARMACY RESIDENT PRACTICE GRANT
UNIVERSITY HOSPITAL
234 GOODMAN STCINCINNATIOH45219311479038501(C)(3)50002010 PHARMACY RESIDENT PRACTICE GRANT
UNIVERSITY OF IOWA
4 JESSUP HALLIOWAS CITYIA52242426004813501(C)(3)132002009 MEDICATION SAFETY TEAM GRANT
UNIVERSITY OF MARYLAND BALTIMORE
620 W LEXINGTON STBALTIMOREMD21201526002033501(C)(3)82502010 PROMOTING INFLUENZA PREVENTION
UNIVERSITY OF ROCHESTER MEDICAL CENTER
601 ELMWOOD AVEROCHESTERNY14642160743209501(C)(3)13670RESIDENCY GRANT/2009 EMERGENCY CARE GRANT
VIRGINIA COMMONWEALTH UNIVERSITY
PO BOX 980568RICHMONDVA232980568546001758501(C)(3)6800JR INVESTIGATOR GRANT
WEST VIRGINIA UNIVERSITY HOSPITAL
1 MEDICAL CENTER DRMORGANTOWNWV26506550643304501(C)(3)6667JR. INVESTIGATOR GRANT
WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION
886 CHESTNUT RIDGE RD RM723MORGANTOWNWV26505550665758501(C)(3)82502010 PROMOTING INFLUENZA PREVENTION
WISHARD FOUNDATION
1001 W 10TH STINDIANAPOLISIN462022879311132066501(C)(3)135982008 MEDICATION SAFETY GRANT
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
4000 AMBASSADOR DRIVEANCHORAGEAK99508920162721501(C)(3)8250FEDERAL SERVICES RESEARCH GRANT
PALO ALTO INSTITUTE FOR RESEARCH & EDUCATION
PO BOX V-38PALO ALTOCA943040038770207331501(C)(3)-120002009 FEDERAL SERVICES GRANT/RESEARCH BOOT CAMP REFUNDS
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants26TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations1TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII (7 entries)

Type Of GrantTypeOfGrantNumber Of RecipientsNumberOfRecipientsAmount Of Cash GrantAmountOfCashGrant
STERILE PRODUCTS OUTSOURCING TOOL PROGRAM1413000
LITERATURE AWARDS PROGRAM1016500
RESEARCH BOOT CAMP13200
STUDENT LEADERSHIP AWARDS1025000
ANTITHROMBOTIC TOOL PANEL1010000
EXCELLENCE AWARDS127600
MULTI-SITE SPECIAL HONORARIA114233

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeXCompensationCommittee
Form990 Of Other OrganizationsXForm990OfOtherOrganizations
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (4 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
HENRI R MANASSE JR PHD SCD
0683798032500029856061000022898083005200
STEPHEN J ALLEN MS FASHP
2195380100000106760249430100150275172000
DANIEL COBAUGH
154062066470465017341098280188343000
RICHARD WALLING
1398360687401774012973017360163193000

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTraded

FieldValueIRS element (for citing)
Non Cash CheckboxXNonCashCheckbox
Number Of Contributions1NumberOfContributions
Noncash Contribs Rptd F99058615NoncashContribsRptdF990
Method Of Determining RevenuesCASH SALE VALUEMethodOfDeterminingRevenues
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGifts
Third Parties Used0ThirdPartiesUsed

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (7 entries)

IdentifierIdentifierExplanationExplanationReturn ReferenceReturnReference
FORM 990, PART VI, SECTION A, LINE 2BUSINESS RELATIONSHIP - MICHAEL S. FLAGSTAD AND LYNNAE M. MAHANEY.
FORM 990, PART VI, SECTION A, LINE 7ATHREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.
FORM 990, PART VI, SECTION A, LINE 8BTHERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS.
ANNUALLY AT THE MARCH MEETINGFORM 990, PART VI, SECTION B, LINE 12C
CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVAULATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE COORDINATES A 360-DEGREE PERFORMANCE REVIEW, SECURING INPUT FROM THE FOUNDATION AND ASHP STAFF, FOUNDATION VOLUNTEERS, AND REPRESENTATIVES FROM THE CORPORATE COMMUNITY WHO HAVE SPONSORED PROGRAMS FOR THE FOUNDATION. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE 360-DEGREE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR CHIEF PHARMACY OFFICERS SINCE THIS IS A LIKELY AND COMPETITIVE CANDIDATE POOL FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARDS CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARAMCIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.FORM 990, PART VI, SECTION B, LINE 15A
THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST.FORM 990, PART VI, SECTION C, LINE 19

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateExempt Code SectionExemptCodeSectionDirect Controlling Entity NADirectControllingEntityNAControlled OrgControlledOrgBusiness Name Line1DirectControllingEntityName/BusinessNameLine1
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)
7272 WISCONSIN AVENUEBETHESDAMD20814520807628TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSIONMD501(C)(6)N/A0
7272 WISCONSIN BUILDING CORPORATION
7272 WISCONSIN AVENUEBETHESDAMD20814521760057TITLE HOLDING COMPANYMD501(C)(2)0AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties0ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org1GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org0LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs0RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs0PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs1PerformOfServicesByOtherOrgs
Sharing Of Facilities1SharingOfFacilities
Sharing Of Paid Employees1SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrg
Other Transfer To Other Org0OtherTransferToOtherOrg
Other Transfer From Other Org1OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (7 entries)

Transaction TypeTransactionTypeAmount InvolvedAmountInvolvedMethod Of Amt DeterminationMethodOfAmtDetermination
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
O1523144RECORDED EXPENSES
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
M679084RECORDED EXPENSES
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
R844059CASH
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
C328400CASH
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
N39323FAIR VALUE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
B24766CASH
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
L81500CASH

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.